Neurocrine Biosciences, Inc.(NBIX)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
NBIX | 17.18 B | 26.29x | 42.20% | 21.55% | $6.50 | 22.50% | 0.14 | - | $171.50 | $122.14 |
MRNA | 24.53 B | -7.59x | 2.60% | -1.44% | $-8.14 | -36.56% | 0.18 | - | $73.90 | $22.28 |
INSM | 23.48 B | -18.81x | 2.30% | -1.44% | $-5.76 | -2.94% | 1.05 | - | $212.75 | $90.39 |
INCY | 23.42 B | 16.54x | 20.90% | 26.71% | $7.09 | 30.82% | 0.70 | - | $116.00 | $66.83 |
UTHR | 22.74 B | 19.81x | -1.60% | 40.62% | $27.04 | 20.26% | - | - | $609.35 | $272.12 |
Peer Valuation & Performance Analysis
Peer group analysis for Neurocrine Biosciences, Inc. (NBIX) compared to its primary competitors (including MRNA, INSM, INCY) reveals distinct metrics. NBIX trades at a valuation premium compared to its competitors, with a P/E ratio of 26.3x versus the peer average of 2.5x (representing a 957% premium). This indicates that the market expects superior growth or commands a quality premium for NBIX. In terms of growth, NBIX's revenue growth of 42.2% exceeds the peer average of 6.0%, highlighting its competitive strength and market share gains. Additionally, it boasts superior profitability with a net margin of 21.6% compared to the peer average of 16.1%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• NBIX ranks #3 in P/E ratio, #1 in revenue growth, and #3 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-07-17 | $169.77 | $172.57 | $169.26 | $170.88 | 929,700 | +0.65% |
| 2026-07-16 | $170.78 | $172.62 | $169.01 | $171.55 | 900,800 | +0.45% |
| 2026-07-15 | $172.04 | $173.12 | $169.44 | $172.05 | 878,300 | +0.01% |
| 2026-07-14 | $177.33 | $177.33 | $169.04 | $172.04 | 1,054,000 | -2.98% |
| 2026-07-13 | $174.50 | $175.88 | $172.03 | $174.10 | 1,573,000 | -0.23% |
| 2026-07-10 | $181.00 | $181.18 | $174.21 | $177.11 | 1,047,400 | -2.15% |
| 2026-07-09 | $178.52 | $181.00 | $177.65 | $180.55 | 1,178,600 | +1.14% |
| 2026-07-08 | $177.70 | $178.63 | $175.28 | $178.24 | 1,155,600 | +0.30% |
| 2026-07-07 | $176.10 | $178.75 | $174.75 | $177.49 | 1,033,800 | +0.79% |
| 2026-07-06 | $175.01 | $175.02 | $171.14 | $174.10 | 922,900 | -0.52% |
| 2026-07-02 | $169.10 | $174.38 | $168.26 | $174.26 | 1,251,000 | +3.05% |
| 2026-07-01 | $169.50 | $169.57 | $165.91 | $167.77 | 927,300 | -1.02% |
| 2026-06-30 | $170.66 | $171.50 | $168.24 | $168.54 | 1,075,600 | -1.24% |
| 2026-06-29 | $168.87 | $171.43 | $167.90 | $170.00 | 1,350,700 | +0.67% |
| 2026-06-26 | $163.59 | $169.56 | $163.12 | $168.52 | 1,953,000 | +3.01% |